Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,027,966 papers from all fields of science
Search
Sign In
Create Free Account
cinacalcet hydrochloride
Known as:
Hydrochloride, Cinacalcet
, 1-Naphthalenemethanamine, a-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-,(aR)-, Hydrochloride
, Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride
Expand
The orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Narrower (1)
AMG 073
Broader (1)
Calcimimetic Agents
In Blood
NCIt Antineoplastic Agent Terminology
agonists
analogs & derivatives
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
K. Eidman
,
J. Wetmore
International Journal of Nephrology and…
2018
Corpus ID: 3377611
Secondary hyperparathyroidism (SHPT) is common in patients receiving maintenance hemodialysis and is associated with adverse…
Expand
Review
2015
Review
2015
Molecular and Clinical Aspects of the Target Therapy with the Calcimimetic Cinacalcet in the Treatment of Parathyroid Tumors.
A. Mingione
,
C. Verdelli
,
A. Terranegra
,
L. Soldati
,
S. Corbetta
Current Cancer Drug Targets
2015
Corpus ID: 22002865
Parathyroid tumors are almost invariably associated with parathormone (PTH) hypersecretion resulting in primary (PHPT) or…
Expand
2013
2013
Cinacalcet Upregulates Calcium-Sensing Receptors of Parathyroid Glands in Hemodialysis Patients
K. Sumida
,
Michio Nakamura
,
+6 authors
K. Ohashi
American Journal of Nephrology
2013
Corpus ID: 34458188
Background: Cinacalcet hydrochloride (cinacalcet), a calcimimetic, has been shown to upregulate calcium-sensing receptor (CaSR…
Expand
2011
2011
Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment
M. Okada
,
Y. Tominaga
,
+8 authors
K. Uchida
Therapeutic apheresis and dialysis
2011
Corpus ID: 23962236
Cinacalcet hydrochloride (cinacalcet) has been reported to be efficacious for patients with tertiary hyperparathyroidism (THPT…
Expand
2011
2011
Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study
Emanuel Zitt
,
C. Jäger
,
+7 authors
B. Watschinger
Wiener Klinische Wochenschrift
2011
Corpus ID: 25186541
ZusammenfassungHINTERGRUND: Trotz extensiven Einsatzes der vorhandenen Standardtherapeutika befindet sich der Großteil der…
Expand
2009
2009
Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
J. Torregrosa
,
C. Bergua
,
M. J. Martínez de Osaba
,
F. Oppenheimer
,
J. Campistol
Transplantation Proceedings
2009
Corpus ID: 22799558
2008
2008
Impact of Cinacalcet Hydrochloride on the Achievement of the Japanese Society for Dialysis Therapy (JSDT) Guideline Targets: A post‐hoc Analysis of the KRN1493 Study
H. Komaba
,
M. Fukagawa
Therapeutic apheresis and dialysis
2008
Corpus ID: 41612510
The Japanese Society for Dialysis Therapy (JSDT) released the Guidelines for the Management of Secondary Hyperparathyroidism in…
Expand
2008
2008
Change in Coronary Artery Calcification Score due to Cinacalcet Hydrochloride Administration
Y. Tsuruta
,
T. Ohbayashi
,
+4 authors
K. Maeda
Therapeutic apheresis and dialysis
2008
Corpus ID: 46568246
We examined the influence of cinacalcet on vascular calcification by measuring the coronary artery calcification score (CACS) in…
Expand
Review
2008
Review
2008
Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3–4 chronic kidney disease
D. Coyne
Nature Clinical Practice Nephrology
2008
Corpus ID: 29289675
In the first of two opposing Viewpoints, Daniel W Coyne questions the use of cinacalcet to treat secondary hyperparathyroidism in…
Expand
2002
2002
Cinacalcet hydrochloride: Treatment of hyperparathyroidism
L. Sorbera
,
R. Castañer
,
M. Bayes
2002
Corpus ID: 79213924
Hyperparathyroidism is characterized by high levels of circulating calcium due to an increased secretion of parathyroid hormone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE